Zusammenfassung
Degenerative Erkrankungen des Herzens stehen in enger Beziehung zum Lebensalter. Sie werden bei den Menschen über 65 Jahre in bis zu 50% angetroffen und sind in dieser Bevölkerungsgruppe etwa zwei-bis dreimal häufiger als in der übrigen Bevölkerung (Abb. 10).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Abbott RD, Donahue RP, Kannel WB, Wilson PW (1988) The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. J Am Med Assoc 260: 3456–3460
Akhras F, Jackson G (1991) Efficacy of nifedipine and isosorbide mononitrate im comination with atenolol in stable angina. Lancet 338: 1036–1039
Akiyama T, Pawitan Y, Campbell WB, Papa L, Barker AH, Rubbert P, Friedman L, Keller M, Josephson RA, CAST-Invest (1992) Effects of advancing age on the efficacy and side effects of antiarrhytmic drugs in post-myocardial infarction patients with ventricular arrhythmia. J Am Geriatr Soc 40: 666–672
Als E, Ammer R, Lehmann G, Pütter K, Ayers GM, Pasquantonio J, Schömig A (1997) Patient characteristics and underlying heart disease as predicators of recurrent atrial fibrillation after internal and external cardioversion in patients treated with oral Sotalol. Am Heart J 134: 419–425
Amiodarone Trials Meta-Analysis Investigators (1997) Effect of prophylactic amiodarone on mortality after acuts myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Lancet 350: 1417–1424
Andersen HR, Nielsen JC, Thomsen PEB, Thuesen L, Mortensen PT, Vesterland T, Pedersen AK (1997) Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 350: 1210–1216
Antiplatelet Trialists Collaboration (1994) Collaborative overview of randomized trials of antiplatelet therapy: 1. prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 308: 81–106
Aronow WS (1997a) Treatment of congestive heart failure in older persons. J Am Geriatr Soc 45: 1252–1258
Aronow WS, Ahn C, Kronzon I (1997b) Effect of propranolol versus no Propranolol on mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction — 40% treated with diuretics plus angiotensin-converting enzyme inhibitors. Am J Cardiol 80: 207–209
Aronow WS, Kronzon I (1993) Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction. Am J Med 71: 602–604
Atrial Fibrillation Investigators (1994) Risk factors for stroke and efficacy of anti-thrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized trials. Arch Intern Med 154: 1449–1457
Baigent C, Collins R, ISIS-2 (1993) 4-year mortality follow-up of 17187 patients after fibrinolytic and antiplatelet therapy in suspected acute myocardial infarction. Circulation 88 [Suppl I]: 291
Basu S, Senior R, Raval U, van der Does R, Bruckner T, Lahiri A (1997) Beneficial effects of intravenous and oral Carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomised trial. Circulation 96: 183–191
Bayer AJ, Chadha JS, Farag RR, Pathy MSJ (1986) Changing presentation of myocardial infarction with increasing old age. J Am Geriatr Soc 34: 263–266
Behar S, Boyko V, Reicher-Reiss H, Goldbourt U, for the SPRINT Study Group (1997) Ten-year survival after acute myocardial infarction: comparison of patients with and without diabetes. Am Heart J 133: 290–296
Bernstein AD, Parsonnet V (1992) Survey of cardiac pacing in the United States in 1989. Am J Cardiol 69: 331–338
Bharati S, Lev M (1992) The pathologic changes in the conduction system beyond the age of ninety. Am Heart J 124: 486–496
Blasini R, Reiniger G, Brügmann U, Rudolph W (1984) Vermeidung einer Toleranzentwicklung unter Isosorbiddinitrat durch Intervalltherapie. Herz 9: 166–170
Blum A, Giladi M, Weinberg M, Kaplan G, Pasternack H, Laniado S, Miller H (1998) High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol 81: 866–868
Boushey CJ, Beresfort SAA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. J Am Med Assoc 274: 1049–1057
Brand FN, Abbott RD, Kannel WB, Wolf PA (1985) Characteristics and prognosis of lone atrial fibrillation. J Am Med Assoc 254: 3449–3453
Buerke M, Pittroff W, Meyer J, Darius H (1995) Aspirin therapy: optimized platelet inhibition with different loading and maintenance doses. Am Heart J 130: 465–472
Cairns JA, Gent M, Singer J, Finnie KJ, Froggatt GM, Holder DA, Jablonsky G, Kostuk WJ, Melendez LJ, Myers MG, Sackett DL, Sealey BJ, Tanser PH (1985) Aspirin, sulfinpyrazone or both in unstable angina. N Engl J Med 313: 1369–1375
Cairns JA, Connolly SJ, Roberts R, Gent M (1997) Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 349: 675–682
Camm AJ, Evans KE, Ward DE, Martin A (1980) The rhythm of the heart in active elderly subjects. Am Heart J 99: 598–603
Carrie D, Elbaz M, Puel J, Fourcarde J, Karouny E, Fournial G, Galinier M (1997) Five-year outcome after coronary angioplasty versus bypass surgery in multivessel coronary artery disease. Circulation 96 [Suppl 2]: 1–6
Castelli WP, Anderson K (1986) A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study. Am J Med 80 [Suppl 2A]: 23–32
Celermajer DS, Sorensen KE, Georgakopoulos D (1993) Cigarette smoking is associated with dose-related and potentially reversible impairement of endothelium-dependent dilation in healthy young adults. Circulation 88: 2149–2155
Channon KM, Hargreaves MR, Cripps TR, Gardner M, Ormerod OJM (1994) DDD vs. VVI pacing in patients aged over 75 years with complete heart block: a double-blind crossover comparison. Quart J Med 87: 245–251
Chur J, Schweid A, Weiss N (1982) Survival among women with endometrial cancer: a comparison of estrogen users and nonusers. Am J Obstet Gynecol Oncol 143: 569–573
Cleveland JC, Meldrum DR, Cain BS, Banerjee A, Harken AH (1997) Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Circulation 96: 29–32
Cohen M, Adams PC, Parry G, Xiong J, Chamberlain D, Wieczorek I, Fox KAA, Chesebro JH, Strain J, Keller C, Kelly A, Lancaster G, Ali J, Kornmal R, Fuster V, and the Antithrombotic Therapy in Acute Coronary Syndroms Research Group (1994) Combination antithrombotic therapy in unstable rest angina and non-Q-Wave infarction in nonprior aspirin users: primary end point analysis from the ATACS trial: antithrombotic therapy in acute coronary syndromes research group. Circulation 89: 81–88
Cohen M, Demers C, Gurfinkel EP (1997) A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 337: 447–452
Cohen I, Wise P (1988) Effect of oestradiol on the diurnal rhythm of serotonon activity in microdissected brain areas of ovarectomized rats. Endocinrology 122: 2619–2625
Cohn JN (1996) The management of chronic heart failure. N Engl J Med 335: 490–498
Cohn JN, Archibald DG, Ziesche S (1986) Effect of vasodilator therapy on mortality on chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med 314: 1547–1552
Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M, Bhat H, Goldman S, Fletcher RD, Diherty J, Hughes CV, Carson P, Cintron G, Shabetai R, Haakenson C (1991) A comparison of enalapril with hydralazine-isosorbid dinitrate in the treatment of congestive heart failure. N Engl J Med 325: 303–310
Colditz GA, Hankinson SE, Hunter DJ, Willett WC, Manson JE, Stampfer MJ, Hennekens C, Rosner B, Speizer FE (1995) The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med 332: 1589–1593
Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH (1990) Blood pressure, stroke, and coronary heart disease. Part 2. Lancet 335: 827–838
Collins R, Peto R, Baigent C, Sleight P (1997) Aspirin, heparin, and fibrinolytic therapy in suspectes acute myocardial infarction. N Engl J Med 336: 847–860
Colvin P, Auerbach B, Case L (1991) A dose response relationship between sex hormone induced change in hepatic triglyceride lipase and high density lipoprotein cholesterol in post menopausal women. Metabolism 40: 1052–1056
Colwell JA (1997) Aspirin therapy in diabetes. Diabetes Care 20: 1767–1771
Corr PB, Gillis RA (1978) Autonomie influences in the dysrhythmia resulting from myocardial infarction. Circ Res 43: 1–9
Corti MC, Guralnik JM, Salive ME, Harris T, Field TS, Wallace RB (1995) HDL cholesterol predicts coronary heart disease mortality in older adults. J Am Med Assoc 274: 539–544
Corti MC, Guralnil JM, Salive ME, Harris T, Ferrucci L, Glynn RJ, Havlik RJ (1997) Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med 126: 753–760
Cox JL, Schuessler RB, Lappas DG, Boineau JP (1996) An 8.5 year experience with surgery for atrial fibrillation. Ann Surg 224: 267–273
Cruz AB, Amatuzio DS, Grnade F, Hay LJ (1961) Effect of intraarterial insulin in tissue cholesterol and fatty acids in alloxan-diabetic dogs. Circ Res 9: 39–43
D’Agostino RB, Belanger AJ, Kannel WB, Cruickchank JM (199) Relation of two diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study. Br J Med 303: 385-389
Dannenberg AL, Levy D, Garrison RJ (1989) Impact of age on echocardiographic left ventricular mass in a healthy population (the Framingham Study). Am J Cardiol 63: 1066–1068
Das DN, Fleg JL, Lakatta EG (1982) Effect of age on the components of atrioventricular conduction in normal man. Am J Cardiol 49: 1031
Davi G, Catalano I, Averna M (1990) Thromboxane biosynthesis and platelet function in type II diabetes mellitus. N Engl J Med 322: 1769–1774
Davies MJ (1988) The pathological basis of arrhythmias. Geriatr Cardiovasc Med 1: 181–183
Davis JW, Davis RF (1979) Acute effects of tobacco cigarette smoking on the platelet aggregate ratio. Am J Med Sci 278: 139–143
De Bakker JM, Van Capelle FJL, Janse MJ (1988) Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation 77: 589–606
de Beider MA, Linker NJ, Jones S, Camm AJ, Ward DE (1992) Cost implications of the British Pacing and Electrophysiology Groups recommendations for pacing. Br Med J 305: 861–865
Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, Arensberg D, Baker A, Friedman L, Greene HL, Huther ML, Richardson DW, and CAST Investigators (1991) Mortality and morbidity in patients receiving encainide, flecainide, or placebo. N Engl J Med 324: 781–788
Edmunds LH, Stephenson LW, Edie RN, Ratcliffe MB (1988) Open-heart surgery in octogenarians. N Engl J Med 319: 131–136
Elder AT, Shaw TRD, Turnball CM, Starkex IR (1991) Elderly and younger patients selected to undergo coronary angiography. Br Med J 303: 950–953
Ellis RW (1997) Infection and coronary heart disease. J Med Microbiol 46: 535–539
European Atrial Fibrillation Trial Study Group (1992) Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 333: 5–10
Fairweather DS (1992) Aging of the heart and the cardiovascular system. Rev Clin Gerontol 2: 83–103
Fibrinolytic Therapy Trialists /FFT) Collaborative Group (1994) Indications for fibrinolytic therapy in suspected acute mycardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 343: 311–322
Fleg JL, Kennedy HL (1982) Cardiac arryhthmias in a healthy elderly population. Chest 81: 302–307
Forte P, Copland M, Smith LM, Sutherland J, Benjamin N (1997) Basal nitric oxide synthesis in essential hypertension. Lancet 349: 837–842
Francis GS (1985) Neurohumoral mechanisms involved congestive heart failure. Am J Cardiol 55: 15A–21A
Furberg CD (1983) Effect of antiarrhythmic drugs on mortality after myocardial infarction. Am J Cardiol 52: 32C–36C
Furberg CD, Psaty BM, Meyer JV (1995) Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 92: 1326–1331
Ganau A, Saba PS, Roman MJ, de Simone G, Realdi G, Devereux RB (1995) Ageing induces left ventricular concentric remodelling in normotensive subjects. J Hypertens 13: 1818–1822
Gent M, Blakely JA, Easton JD, Ellis DJ, Hachinski VC, Harbison JW, Panak E, Roberts RS, Sicurella J, Turpie AGG, and the CATS Group (1989) The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet i: 1215–1220
Gerstenblith G, Frederiksen J, Yin FCP, Fortuin NJ, Lakatta EG, Weisfeldt ML (1977) Echocardiographic assessment of a normal adult aging population. Circulation 56: 273–278
Ghali JK, Cooper R, Ford E (1990) Trends in hospitalization rates for heart failure in the United States, 1973–1986. Arch Intern Med 150: 769–773
Glynn RJ, Field TS, Rosner B, Hebert PR, Taylor JO, Hennekens CH (1995) Evidence for a positive linear relation between blood pressure and mortality in elderly people. Lancet 345: 825–829
Gold S, Wong WF, Schatz IJ, Blanchette PL (1991) Invasive treatment for coronary artery disease in the elderly. Arch Intern Med 151: 1085–1088
Goldberg RJ, Gore JM, Gurwitz JH, Alpert JS, Brady P, Strohsnitter W, Chen Z, Dalen JE (1989) The impact of age on the incidence and prognosis of initial acute myocardial infarction: The Worcester Heart Attack Study. Am Heart J 117: 543–549
Gottlieb SS, Kukin ML, Ahern D, Packer M (1989) Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 13: 1534–1539
Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117: 1016–1037
Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O’Keefe J, Overlie B, Donohue B, Chelliah N, Timmis GC, Vlietastra RE, Strzelecki M, Puchrowicz-Ochocki S, Oneill WW, for the Primary Angioplasty in Myocardial Infarction Study Group (1993) A comparison of immediate angioplasty with thrombolytic therapy for myocardial infarction. N Engl J Med 328: 673–679
Grodstein F, Stampfer MJ, Colditz GA, Willett WC, Manson JE, Hoffe M, Rosner B, Fuchs C, Haninsor SE, Hunter DJ, Hennekens CH, Speitzer FE (1997) Postmenopausal hormone therapy and mortality. N Engl J Med 336: 1769–1775
Grossman W (1991) Diastolic dysfunction in congestive heart failure. N Engl J Med 32: 1557–1564
Gum PA, O’Keefe JH, Borkon AM, Spertus JA, Bateman TM, McGraw JP, Sherwani K, Vacek J, McCallister BD (1997) Bypass surgery versus coronary angioplasty for revascularization of treated diabetic patients. Circulation 96 [Suppl 2]: 7–10
Gupta S, Camm AJ (1997) Chronic infection in the etiology of atherosclerosis — the case for Chlamydia pneumoniae. Clin Cardiol 20: 829–836
Hall AS, Murray GD, Ball SG, and the AIREX Study Investigators (1997) Follow-up study of patients randomly allocated ramipril of placebo for heart failure after myocardial infarction: AIRE Extrension (AIREX) Study. Lancet 349: 1493–1497
Hansten PD (1979) Drug interactions. Lea & Febiger, Philadelphia, p 253
Hargreaves MR, Ormerod O (1994) Physiological pacing for elderly patients: exploit the benefits but don’t overdo it. Age Ageing 23: 441–444
Harrison TR, Dixon K, Russel RO, Bidwai PS, Coleman HN (1964) The relation of age to the duration of contraction, ejection and relaxation of the normal human heart. Am Heart J 67: 189
Hasdai D, Garratt KN, Grill DE, Lerman A, Holmes DR (1997) Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med 336: 755–761
Hawkins CM, Richardson DW, Vokonas PS, Betablocker Heart Attack Trial Group (1983) Effect of Propranolol in reducing mortality in older myocardial infarction patients. The betablocker heart attack trial experience. Circulation 57 [Suppl 1]: 94–97
Heaney RP, Recker RR, Saville PD (1978) Menopausal changes in bone remodeling. J Lab Clin Med 92: 964–970
Holder DA, Jablonsky G, Kostuk WJ, Merendez LJ, Myers HG, Sackett DL, Sealey BJ, Tanser PH (1985) Aspirin sulfinpyrazone or both in unstable angina. N Engl J Med 313: 1369–1375
Holland KJ, O’Neill WW, Bates ER, Pitt B, Topol EJ (1989) Emergency percutaneous transluminal coronary angioplasty during acute myocardial infarction for patients more than 70 years of age. Am J Cardiol 63: 399–403
Hoorntje JC, Suryapranata H, de Boer M-J, Zijlstra F, van Hof AW, van den Brink L, ESCOBAR (1996) ESCOBAR: primary stenting for acute myocardial infarction: preliminary results of a randomized trial. Circulation 94 [Suppl 1]: 570
Hunink MGM, Goldman L, Tosteson ANA, Mittleman MA, Goldman PA, Williams LW, Tsevat J, Weinstein MC (1997) The recent decline in mortality from coronary heart disease, 1980-1990. J Am Med Assoc 277: 535–542
ISIS-1 (First International Study of Infarct Survival) Collaborative Group (1986) Randomized trial of intravenous atenolol among 16, 027 cases of suspected acute myocardial infarction: ISIS-1. Lancet ii: 57–65
ISIS-2 (Second International Study of Infarct Survival) Collaborative Group (1988) Randomized trial of intravenous Streptokinase, oral aspirin, both, or neither among 17, 187 cases of suspected acute myocardial infarction: ISIS-2. Lancet ii: 349–360
Julian DG, Camm AJ, Frangin G, Janse M, Munoz A, Schwartz PJ, Simon P, EMIAT-Invest (1997) Randomized trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 349: 667–674
Juul-Möller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Ömbius R, for the Swedish Angina Pectoris Aspirin Trial (SAPAT) Group (1992) Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable angina pectoris. Lancet 340: 1421–1425
Kannel WB (1977) Prevention of heart disease in the young coronary candidate. Primary Care 4: 229–243
Kannel WB, Abbott RD, Savage DD, McNamara PM (1982) Epidemiological features of chronic atrial fibrillation. N Engl J Med 306: 1018–1022
Kannel WB, Abbott RD (1984) Incidence and prognosis of unrecognized myocardial infarction. N Engl J Med 311: 1144–1147
Kannel WB, Belanger AJ (1991) Epidemiology of heart failure. Am Heart J 121: 951–957
Kannel WB, Wolf PA, Garrison RJ. The Framingham Study, Section 34: Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biannual measurements. National Institutes of Health Publication No 87-2803
Kendall MJ, Lynch KP, Hjalmarson A, Kjekshus J (1995) Beta-blockers and sudden cardiac death. Ann Intern Med 123: 358–367
Kendall MJ (1997) Clinical relevance of pharmacokinetic differences between beta blockers. Am J Cardiol 80(9B): 15J–19J
Kennedy HL, Whitlock JA, Sprague MK, Kennedy LJ, Buckingham TA, Goldberg RJ (1985) Longterm follow-up of asymptomatic healthy subjects with frequent and complex ventricular ectopy. N Engl J Med 312: 193–197
Kloner R, Shook T, Przyklenk K, Davis VG, Junio L, Matthews RV, Burstein S, Gibson SM, Poole WK (1995) Previous angina alters in-hospital outcome in TIMI 4. Circulation 91: 37–47
Kostis JB, Moreyra AE, Natarajan N, Gotzoyannis S, Hosier M, McCrone K, Kuo PT (1979) Ambulatory electrocardiography: what is normal? Am J Cardiol 43: 420
Kostis JB, Moreyra AE, Amendo MT, Di Pietro J, Cosgrove N, Kuo PT (1982) The effect of age on heart rate in subjects free of heart disease. Circulation 65: 141–145
Kostis JB, Davis BR, Cutler J, Grimm RH, Berge KG, Cohen JD, Lacy CR, Perry HM, Blaufox MD, Wassertheil-Smolle S, Black HR, Schron E, Berkson DM, Curb JD, Smith WM, McDonald R, Applegate WB, and the SHEP Cooperative Research Group (1997) Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. J Am Med Assoc 278: 212–216
Kusumoto FM, Goldschlager N (1996) Cardiac pacing. N Engl J Med 334: 89–98
La Croix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berkman L, Curb JD, Evans D, Hennekens CH (1991) Smoking and mortality among older men and women in three communities. N Engl J Med 324: 1619–1625
Lakatta EG, Yin FCP (1982) Myocardial aging: functional alterations and related cellular mechanisms. Am J Physiol 242: H927–H941
Lakatta EG (1980) Age-related alterations in the cardiovascular response to adrenergic mediated stress. Federation Proc 39: 3173–3177
Lakatta EG (1990) Similar myocardial effects of aging and hypertension. Eur Heart J 11: 29–38
Lakatta EG (1993) Deficient neuroendocrine regulation of the cardiovascular system with advancing age in healthy humans. Circulation 87: 631–636
Laster SB, Rutherford BD, Giorgi LV, Shimshak TM, McConahay DR, Johnson WL, Huber KC, Ligon RW, Hartzler GO (1996) Results of direct percutaneous transluminal coronary angioplasty in octogenerians. Am J Cardiol 77: 10–13
Le-Feuvre CA, Connolly SJ, Cairns JA, Gent M, Roberts RS (1996) Comparison of mortality from acute myocardial infarction between 1979 and 1992 in a geographically-defined stable population. Am J Cardiol 78: 1345–1349
Leppo LA, O’Brien J, Rothendler JA, Getchell JD, Lee VW (1984) Dipyridamole-Thallium-201 scintigraphy in the prediction of future cardiac events acute myocardial infarction. N Engl J Med 310: 1014–1018
Levine TB (1985) Role of vasidilators in the treatment of congestive heart failure. Am J Cardiol 55: 32A–35A
Levy D, Wilson PWF, Anderson KM, Castelli WP (1990) Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study. Am Heart J 119: 12–17
Lichtlen PR (1983) Unstabile Angina pectoris und Prä-Infarktsyndrom. Internist 24: 372–382
Lie JT, Hammond PI (1988) Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patients 90 to 105 years old. Mayo Clin Proc 63: 552–564
Linzbach AJ, Akuamoa-Boateng E (1973) Die Altersveränderungen des menschlichen Herzens. Die Polypathie des Herzens im Alter. Klin Wochenschr 51: 164–175
Luchi RJ, Taffe GF, Teasdale TA (1991) Congestive heart failure in the elderly. J Am Geriatr Soc 39: 810–825
MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J (1990) Blood pressure, stroke, and coronary heart disease. Part 1. Lancet 335: 765–774
Malmberg K, for the DIGAMI (Diabetes mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group (1997) Prospective randomised study of intensive insulin treatment on long term survival after myocardial infarction in patients with diabetes mellitus. Br Med J 314: 1512–1515
Markham RV, Corbett JR, Gilmore A (1983) Efficacy of prazosin in the management of chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 51: 1346–1352
Maseri A (1983) Angina pectoris: the new emerging face. Triangel 22/1: 23–30
McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of congestive heart failure: The Framingham Study. N Engl J Med 285: 1441–1446
Messerli FH, Michalewicz L (1997) Safety of heart rate-lowering calcium antagoniste: lessons from controlled trials. Am Heart J 134: S21–S24
Miettinen TA, Pyörälä K, Olsson AG, Musliner TA, Cook TJ, Faergeman O, Berg K, Pedersen T, Kjekshus J, for the Scandinavian Simvastatin Study Group (1997) Cholesterol-lowering therapy in women and elderly patients with myocardial infarction of angina pectoris. Circulation 96: 4211–4218
Mihalick MJ, Fisch C (1974) Electrocardiographic findings in the aged. Am Heart J 87: 117–128
Moncada S (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002–2012
Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ (1995) Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. N Engl J Med 332: 1198–1203
Nabulsi AA, Folsom AR, White A, Patsch W, Heiss G, Wu KK, Szklo M, for the Atherosclerosis Risk in Communities Study Investigators (1993) Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 328: 1069–1075
Narayan S, Cain ME, Smith JM (1997) Atrial fibrillation. Lancet 350: 943–950
Nelson RD, Ezri MD, Denes P (1984) Arrhythmias and conduction disturbances in the elderly. In: Messerli FJ (ed) Cardiovascular disease in the elderly. Marinus Nijhoff, Boston, pp 83–107
Nolan L, O’Malley K (1988) Prescribing for the elderly. Part I. Sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc 36: 142, 149
Nygard O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE (1997) Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337: 230–236
Olivetti G, Melissari M, Capasso JM, Anversa P (1991) Cardiomyopathy of the aging human heart. Circul Res 68: 1560–1568
Oswald GA, Corcoran S, Yudkin JS (1984) Prevalence and risks of hyperglycaemia and undiagnosed diabetes in patients with acute myocardial infarction. Lancet i: 1264–1267
Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH, for the U.S. Carvedilol heart failure Study Group (1996a) The effect of Carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334: 1349–1355
Packer M, O’Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, Miller AB, Neuberg GW, Frid PE, Wertheimer JH, Cropp AB, DeMets AL, and the PRAISE Study Group (1996b) Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 335: 1107–1114
Panotopoulos PT, Axtell K, Anderson AJ, Sra J, Blanck Z, Despande S, Biehl M, Keelan ET, Jazayeri MR, Akhtar M, Dhala A (1997) Efficacy of the implantable cardioverter-defibrillator in the elderly. J Am Coll Cardiol 29: 556–560
Park KC, Forman DE, Wie JY (1995) Utility of beta-blockade treatment for older postinfarction patients. J Am Geriatr Soc 43: 751–755
Petri M, Roubenoff R, Dallai GE, Nadeau MR, Selhub J, Rosenberg IH (1996) Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 348: 1120–1124
Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI, and the ELITE Study Investigators (1997) Randomized trial of losartan versus Captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 349: 747–752
Platia EV, Michelson EL, Proterfield JK, Das G (1989) Esmolol versus Verapamil in the acute treatment of atrial fibrillation or atrial flutter. Am J Cardiol 63: 925–929
Podrid PJ (1995) Amiodarone: re-evaluation of an old drug. Ann Intern Med 122: 689–700
Pomerance A (1965) Pathology of the heart with and wothout cardiac failure in the aged. Br Heart J 27: 697–710
Psaty BM, Manolio TA, Kuller LH, Kronmal RA, Cushman M, Fried LP, White R, Furberg CD, Rautaharju PM (1997) Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96: 2455–2461
Pyärälä K, Olsson AG, Pedersen TR, Thorgeirson G, Kjekshus J, Faereman O (1997) Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. Diabetes Care 20: 614–620
Rakugi H, Yu H, Kamitani A, Nakamura Y, Ohishi M, Kamide K, Nakata Y, Takami S, Higaki J, Ogihara T (1996) Links between hypertension and myocardial infarction. Am Heart J 132: 213–221
Rich MW (1997) Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc 45: 968–974
Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336: 973–979
Ridker PM (1998) C-reactive protein and risk of future myocardial infarction and thrombotic stroke. Europ Heart J 19: 1–3
Rigby JW, Scott AK, Hawkswrth GM, Petrie JC (1985) A comparison of the pharmacokinetics of atenolol, metoprolol, oxyprenol, and propranolol in elderly hypertensive and young healthy subjects. Br J Clin Pharmacol 20: 327
Rimm EB, Willet WC, Hu FB, Sampson L, Colditz GA, Manson JE, Hennekens C, Stampder MJ (1998) Folate and vitamin B6 from diet and supplements in relation to risk of coronaryheart disease among women. J Am Med Assoc 279: 359–364
Ritchie JL, Phillips KA, Luft HS (1993) Coronary angioplasty: statewide experience in California. Circulation 88: 2735–2743
Rodeheffer RJ, Gerstenblith G, Becker LC, Fleg JL, Weisfeldt ML, Lakatta EG (1984) Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilation and increased stroke volume compensate for diminished heart rate. Circulation 69: 203–213
Ross T (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801–809
Rotmensch HH, Belhassen B (1988) Amiodarone in the management of cardiac arrhythmias: current concepts. Med Clin North Am 72: 321–358
Rupprecht H-J, Darius H, Meyer J (1997) Aktuelle Therapie der koronaren Herzkrankheit. Internist 38: 1179–1190
Savage MP, Douglas JS, Fischman DL (1997) Stent placement compared with balloon angiopasty for obstructed coronary bypass grafts. N Engl J Med 337: 740–747
Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Survival Study (48). Lancet 344: 1383–1389
Schocke DD (1992) Cardiac disease. Rev Clin Gerontol 2: 207–226
Schrör K (1995) Antiplatelet drugs. A comparative review. Drugs 50: 7–28
Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. I Am Med Assoc 270: 2693–2698
Serruys PW, Herrman J-PR, Simon R, Rutsch W, Bode C, Laarman G-J, van Dijk R, van den Bos AA, Umans VAWM, Fox KAA, Close P, Deckers JW, for the HELVETICA Investigators (1995) A comparison of hirudin with heparin in the prevention of restenosis after coronary angioplasty. N Engl J Med 333: 757–763
Setaro JF, Zaret BL, Schulman DS (1990) Usefulness of Verapamil for congestive heart failure associated with abnormal left ventricular distolic filling and normal left ventricular systolic performance. Am J Cardiol 66: 981–986
SHEP Cooperative Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. J Am Med Assoc 265: 3255–3264
Shepard J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ, for the West of Scotland Coronary Prevention Study Group (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterinemia. N Engl J Med 333: 1301–1307
Shetty IIGM, Woodhouse KW (1992) Use of amiodarone for elderly patients. Age Ageing 21: 233–236
Simoons ML, de Boer MJ, van den Brand MJBM, van Miltenbrug AJM, Horrntje JCA, Hendrickx GR, van der Wieken LR, De Bono D, Rutsch W, Schaible TF, Weisman HE, Klootwijk P, Nijssen KM, Stibbe J, Feyter PJ, and the European Cooperative Study Group (1994) Randomized trial of GP IIb/IIIa platelet receptor blocker in refractory unstable angina. Ciruclation 89: 596–603
Singer DE, Moulton AW, Nathan DM (1989) Diabetic myocardial infarction. Interaction of diabetes with other preinfarction risk factors. Diabetes 38: 350–357
Singh BN (1990) Advantages of beta-blockers versus anti-arrhythmic agents and calciumantagonstits in secondary prevention after myocardial infarction. Am J Cardiol 66: 9C–20C
Singh BN (1991) Principles of pharmacologic and nonpharmacologic therapy. In: Weiss JN (ed) Ventricular arrhythmias in ischemic heart disease. Ann Intern Med 114: 784–797 (792-795)
Slany J (1984) Akuter Myokardinfarkt beim alten Menschen. Fortschr Med 102: 507–511
Sorbini CA, Grassi V, Solinas E, Muiesan G (1968) Arterial oxygen tension in relation to age in healthy subjects. Respiration 25: 3–13
Stampfer MJ, Malinow MR, Willet WC, Newcomer LM, Upson B, Ullman D, Tishler PV, Hennekens CH (1992) A prospective study of plasma homocystein and risk of myocardial infarction in US physicians. J Am Med Assoc 268: 877–881
Stanord L, Weiss N, Voigt L, Daling J, Habel L, Rossing M (1995) Combined oestrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle aged women. J Am Med Assoc 274: 178–179
Stratton JR, Cerqueria MD, Schwartz RS, Levy WC, Veith RC, Kahn SE, Abrass IB (1992) Differences in cardiovascular responses to isoproterenol in relation to age and exercise training in healthy men. Circulation 86: 504–512
Sutton R (1988) The use of cardiac pacemakers. Geriatr Cardiovascular Med 1: 197–199
Swedberg K, Held P, Kjekhus J, Rasmussen K, Ryden I, Wedel H, the CONSENSUS II Study Group (1992) Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. N Engl J Med 327: 678–684
Sytkowski PA, Kannel WB, De Agostino RB (1990) Changes in risk factors and the decline in mortality from cardiovascular disease: the Framingham Heart Study. N Engl J Med 322: 1635–1641
Tan KH, Sulke N, Taub N, Karani S, Sowton E (1995) Percutaneous transluminal coronary angioplasty in patients 70 years of age or older: 12 years experience. Br Heart J 74: 310–317
Task Force of the Working Group on Arrhythmias of the European Society of Cardiology (1994) The early termination of clinical trials: causes, consequences, and control, with special reference to trials in the field of arrhythmias and sudden death. Circulation 89: 2892–2907
Teirstein PS (1998) Radiotherapy to inhibit coronary restenosis: kind of a light at the end of the tunnel. Europ Heart J 19: 3–6
Teo K, Yusuf S, Furberg C (1993) Effect of antiarrhythmic drug therapy in acute myocardial infarction: an overview of results from randomized controlled trials. J Am Med Assoc 270: 1589–1595
The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators (1994) The effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 342: 821–828
The Bypass Angioplasty Revascularization Investigation (BARI) Investigators (1996) Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335: 271–275
The CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 316: 1429–1435
The Digitalis Investigation Group (1997) The effect of dogoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336: 525–533
The EPIC Investigators (1994) Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 330: 956–961
The EPILOG Investigators (1997) Platelet glycoprotein IIb/IIIa receptor blockade and lowdose heparin during percutaneous coronary revascularization. N Engl J Med 336: 1689–1696
The Global Use of Strategies to Open occluded coronary arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators (1997) A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 336: 1621–1628
The GUSTO-IIb Investigators (1996) A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 335: 775–782
The Multicenter Postinfarction Research Group (1983) Risk stratification and survival after myocardial infarction. N Engl J Med 309: 331–336
The Norwegian Multicenter Study (1981) Tmilolinduced reduction in mortality and reinfarction in patients surviving acute myocardial infarction. N Engl J Med 304: 801–807
The Pooling Project Research Group (1978) Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. J Chron Dis 31: 201–306
Topol EJ, Califf RM (1992) Thrombolytic therapy for elderly patients. N Engl J Med 327: 45–47
Topol EJ, Fuster V, Harrington RA, Califf RM, Kleiman NS, Kereiakis DJ, Cohen M, Chapekis A, Gold HK, Tannenbaum NA, Rao AK, Debowey D, Schwartz D, Henis M, Chesebro J (1994) Recombinant hirudin for unstable angina pectoris. A multicenter randomized angiographic trial. Circulation 89: 1557–1566
Tragl KH (1983) Risikofaktoren und atherosklerotische Komplikationen in Wien: Herzinfarkt und Schlaganfall. Acta Med Austr 10: 1–10
Tresch DD, McGough MF (1995) Heart failure with normal systolic function: a common disorder in older people. 1 Am Geriatr Soc 1035-1042
Tresch DD (1997) The clinical diagnosis of heart failure in older patients. J Am Geriatr Soc 45: 1128–1133
Tröster S, Schuster H-P, Bodmann KF (1991) Vorhofflimmern bei Patienten einer medizinischen Klinik — ein Marker für Multimorbidität und ungünstige Prognose. Med Klinik 86: 338–343
Tsai TP, Matloff JM, Chaux A, Kass RM, Lee ME, Czer LSC, DeRobertis RN, Gray RJ (1986) Combined valve and coronary artery bypass procedures in septuagenerians and octogenerians: results in 120 patients. Ann Thorac Surg 42: 681–684
Vigilante GJ, Weintraub WS, Klein LW, Schneider RM, Seelaus PA, Parr GVS, Agarwal JB, Heltant RH (1986) Medical and surgical survival in coronary artery disease in the 1980s. Am J Cardiol 58: 926–931
Voigt L, Weiss N, Chu J, Daling J, McKnight B, van Belle G (1991) Progestagen supplementation of exogenous oestrogens and the risk of endometrial cancer. Lancet 338: 274–277
Waldo AL, Camm AJ, de Ruyter H, Friedman PL, McNeil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP, for the SWORD Investigators (1996) Effect of Sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 348: 7–12
Wallen T, Landahl S, Hedner T, Hall C, Saito Y, Nakao K (1997) Atrial natriuretic peptides predict mortality in the elderly. J Intern Med 241: 269–275
Waller BF, Roberts WC (1983) Cardiovascular disease in the very elderly. Am J Cardiol 51: 403–421
Wie JY (1992) Age and the cardiovascular system. N Engl J Med 327: 1735–1739
Weigner MJ, Caulfield TA, Danias PG, Silverman DI, Manning WJ (1997) Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours. Ann Intern Med 126: 615–620
Willett W, Hennekens CH, Castelli W (1983) Effects of cigarette smoke on fasting triglyceride, total cholesterol, and HDL-cholesterol in women. Am Heart J 105: 417–421
Willett WC, Green A, Stampfer MJ, Speizer FE, Colditz GA, Rosner B, Monson RR, Stason W, Hennekens CH (1987) Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 317: 1303–1309
Xiao RP, Lakatta EG (1991) Mechanism of altered beta-adrenergic modulation of the cardiovascular system with aging. Rev Clin Gerontol 1: 309–322
Yin FC, Raizes GS, Guarnieri T, Spurgeon HA, Lakatta EG, Fortuin NJ, Weisfeldt ML (1978) Age-associated decrease in ventricular response to haemodynamic stress during betaadrenergic blockers. Br Heart J 40: 1349–1355
Yusuf S, Collins R, MacMahon S, Peto R (1988) Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials. Lancet i: 1088–1092
Zijlstra F, de Boer MJ, Horrntje JCA, Reiffers S, Reiber JHC, Suryapranata H (1993) A comparison of immediate coronary angioplasty with intravenous Streptokinase in acute myocardial infarction. N Engl J Med 328: 680–684
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Wien
About this chapter
Cite this chapter
Tragl, K.H. (1999). Das Herz des alternden Menschen. In: Handbuch der Internistischen Geriatrie. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6409-9_5
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6409-9_5
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-7317-6
Online ISBN: 978-3-7091-6409-9
eBook Packages: Springer Book Archive